The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
β-Thalassemias
Abstract
Defective synthesis of the β-globin chain causes recessively inherited disorders characterized by inadequate hemoglobin production and chronic anemia. Transfusion may lead to iron overload. Hematopoietic stem-cell transplantation may be curative. Gene therapy holds promise for reversing anemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962
Self-citationGlobal epidemiology of haemoglobin disorders and derived service indicators
Modell, B. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.06.036673 · Cited by 1,924
Wood, J. C., Enriquez, C., Ghugre, N., Tyzka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2005) · Blood · doi:10.1182/blood-2004-10-3982 · Cited by 1,045
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
St. Pierre, T. G., Clark, P. R., Chua-anusorn, W., Fleming, A. J., Jeffrey, G. P., Olynyk, J. K., Pootrakul, P., Robins, E., & Lindeman, R. (2005) · Blood · doi:10.1182/blood-2004-01-0177 · Cited by 909
Survival in Medically Treated Patients with Homozygous β-Thalassemia
Olivieri, N. F., Nathan, D. G., MacMillan, J. H., Wayne, A. S., Liu, P. P., McGee, A., Martin, M., Koren, G., & Cohen, A. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310903 · Cited by 852
Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31822-6 · Cited by 807
Self-citationGene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Thompson, A. A., Walters, M. C., Kwiatkowski, J., Rasko, J. E. J., Ribeil, J.-A., Hongeng, S., Magrin, E., Schiller, G. J., Payen, E., Semeraro, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705342 · Cited by 684
Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major
Angelucci, E., Brittenham, G. M., McLaren, C. E., Ripalti, M., Baronciani, D., Giardini, C., Galimberti, M., Polchi, P., & Lucarelli, G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430503 · Cited by 607
Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
Kirk, P., Roughton, M., Porter, J. B., Walker, J. M., Tanner, M. A., Patel, J., Wu, D., Taylor, J., Westwood, M. A., Anderson, L. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.874487 · Cited by 597
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
The hypercoagulable state in thalassemia
Eldor, A., & Rachmilewitz, E. A. (2002) · Blood · doi:10.1182/blood.v99.1.36 · Cited by 503
Pennell, D. J. (2006) · Blood · doi:10.1182/blood-2005-07-2948 · Cited by 495
On T2* Magnetic Resonance and Cardiac Iron
Carpenter, J.-P., He, T., Kirk, P., Roughton, M., Anderson, L. J., de Noronha, S. V., Sheppard, M. N., Porter, J. B., Walker, J. M., Wood, J. C., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.007641 · Cited by 485
Tanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., Roughton, M., Assomull, R., Nair, S. V., Walker, J. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.648790 · Cited by 482
Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch
Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478
Suragani, R. N. V. S., Cadena, S. M., Cawley, S. M., Sako, D., Mitchell, D., Li, R., Davies, M. V., Alexander, M. J., Devine, M., Loveday, K. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3512 · Cited by 445
Angelucci, E., Matthes-Martin, S., Baronciani, D., Bernaudin, F., Bonanomi, S., Cappellini, M. D., Dalle, J.-H., Di Bartolomeo, P., de Heredia, C. D., Dickerhoff, R., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.099747 · Cited by 399
Self-citationTaher, A. T., Musallam, K. M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., Saned, M.-S., El-Chafic, A.-H., Fasulo, M. R., & Cappellini, M. D. (2010) · Blood · doi:10.1182/blood-2009-09-243154 · Cited by 392
Self-citationPiel, F. B., & Weatherall, D. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404415 · Cited by 392
Iron-Chelating Therapy for Transfusional Iron Overload
Brittenham, G. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1004810 · Cited by 366
A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia.
Cappellini, M. D., Viprakasit, V., Taher, A. T., Georgiev, P., Kuo, K. H. M., Coates, T., Voskaridou, E., Liew, H.-K., Pazgal-Kobrowski, I., Forni, G. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910182 · Cited by 332
Self-citationChanging patterns in the epidemiology of β‐thalassemia
Kattamis, A., Forni, G. L., Aydinok, Y., & Viprakasit, V. (2020) · European Journal of Haematology · doi:10.1111/ejh.13512 · Cited by 331
Non-transfusion-dependent thalassemias
Musallam, K. M., Rivella, S., Vichinsky, E., & Rachmilewitz, E. A. (2013) · Haematologica · doi:10.3324/haematol.2012.066845 · Cited by 326
Self-citationAn abundant erythroid protein that stabilizes free α-haemoglobin
Kihm, A. J., Kong, Y., Hong, W., Russell, J. E., Rouda, S., Adachi, K., Simon, M. C., Blobel, G. A., & Weiss, M. J. (2002) · Nature · doi:10.1038/nature00803 · Cited by 281
Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management
Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582 · Cited by 273
Fucharoen, S., & Weatherall, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011734 · Cited by 248
Marktel, S., Scaramuzza, S., Cicalese, M. P., Giglio, F., Galimberti, S., Lidonnici, M. R., Calbi, V., Assanelli, A., Bernardo, M. E., Rossi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0301-6 · Cited by 225
Self-citationCappellini, M. D., Bejaoui, M., Agaoglu, L., Canatan, D., Capra, M., Cohen, A., Drelichman, G., Economou, M., Fattoum, S., Kattamis, A., et al. (2011) · Blood · doi:10.1182/blood-2010-11-316646 · Cited by 222
Self-citationReducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Guo, S., Casu, C., Gardenghi, S., Booten, S., Aghajan, M., Peralta, R., Watt, A., Freier, S., Monia, B. P., & Rivella, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66969 · Cited by 222
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
Antoniani, C., Meneghini, V., Lattanzi, A., Felix, T., Romano, O., Magrin, E., Weber, L., Pavani, G., El Hoss, S., Kurita, R., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811505 · Cited by 194
Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial
Maggio, A., D'Amico, G., Morabito, A., Capra, M., Ciaccio, C., Cianciulli, P., Di Gregorio, F., Garozzo, G., Malizia, R., Magnano, C., et al. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0510 · Cited by 192
Musallam, K. M., Cappellini, M. D., Wood, J. C., Motta, I., Graziadei, G., Tamim, H., & Taher, A. T. (2011) · Haematologica · doi:10.3324/haematol.2011.047852 · Cited by 177
Self-citationAmelioration of Sardinian 0 thalassemia by genetic modifiers
Galanello, R., Sanna, S., Perseu, L., Sollaino, M. C., Satta, S., Lai, M. E., Barella, S., Uda, M., Usala, G., Abecasis, G. R., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217901 · Cited by 164
Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia
Kong, Y., Zhou, S., Kihm, A. J., Katein, A. M., Yu, X., Gell, D. A., Mackay, J. P., Adachi, K., Foster-Brown, L., Louden, C. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21982 · Cited by 158
Suragani, R. N. V. S., Cawley, S. M., Li, R., Wallner, S., Alexander, M. J., Mulivor, A. W., Gardenghi, S., Rivella, S., Grinberg, A. V., Pearsall, R. S., et al. (2014) · Blood · doi:10.1182/blood-2013-06-511238 · Cited by 152
Pennell, D. J., Porter, J. B., Cappellini, M. D., Chan, L. L., El-Beshlawy, A. M., Aydınok, Y., Ibrahim, H. M., Li, C. K., Viprakasit, V., Elalfy, M. S., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.049957 · Cited by 141
Self-citationPsatha, N., Reik, A., Phelps, S. R., Zhou, Y., Dalas, D., Yannaki, E., Levasseur, D. N., Urnov, F. D., Holmes, M. C., & Papayannopoulou, T. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.08.003 · Cited by 131
How I manage medical complications of β-thalassemia in adults
Taher, A. T., & Cappellini, M. D. (2018) · Blood · doi:10.1182/blood-2018-06-818187 · Cited by 129
Self-citationPennell, D. J., Porter, J. B., Piga, A. G., Lai, Y., El-Beshlawy, A. M., Belhoul, K., Elalfy, M. S., Yeşilipek, A., Kılınç, Y., Lawniczek, T., et al. (2014) · Blood · doi:10.1182/blood-2013-04-497842 · Cited by 123
Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia
Rivella, S. (2019) · Blood · doi:10.1182/blood-2018-07-815928 · Cited by 120
Piga, A., Perrotta, S., Gamberini, M. R., Voskaridou, E., Melpignano, A., Filosa, A., Caruso, V., Pietrangelo, A., Longo, F., Tartaglione, I., et al. (2019) · Blood · doi:10.1182/blood-2018-10-879247 · Cited by 119
Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia
Khandros, E., Thom, C. S., D'Souza, J., & Weiss, M. J. (2012) · Blood · doi:10.1182/blood-2011-12-397729 · Cited by 116
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation
Basak, A., Munschauer, M., Lareau, C. A., Montbleau, K. E., Ulirsch, J. C., Hartigan, C. R., Schenone, M., Lian, J., Wang, Y., Huang, Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0568-7 · Cited by 105
Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia
Manolova, V., Nyffenegger, N., Flace, A., Altermatt, P., Varol, A., Doucerain, C., Sundstrom, H., & Dürrenberger, F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129382 · Cited by 98
Cerebral infarction in β-thalassemia intermedia: Breaking the silence
Musallam, K. M., Taher, A. T., Karimi, M., & Rachmilewitz, E. A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.07.013 · Cited by 92
Self-citationIncreasing prevalence of thalassemia in America: Implications for primary care
Sayani, F. A., & Kwiatkowski, J. L. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1091942 · Cited by 91
Angastiniotis, M., Corrons, J. V., Soteriades, E. S., & Eleftheriou, A. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/727905 · Cited by 88
Manfrè, L., Giarratano, E., Maggio, A., Banco, A., Vaccaro, G., & Lagalla, R. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.173.6.10584785 · Cited by 80
International survey of T2* cardiovascular magnetic resonance in -thalassemia major
Carpenter, J. P., Roughton, M., Pennell, D. J., & the Myocardial Iron in Thalassemia (MINT) Investigators (2013) · Haematologica · doi:10.3324/haematol.2013.083634 · Cited by 78
Taher, A. T., Porter, J. B., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., Siritanaratkul, N., Galanello, R., Karakaş, Z., Lawniczek, T., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1808-z · Cited by 74
Self-citationMaggio, A., Kattamis, A., Felisi, M., Reggiardo, G., El-Beshlawy, A. M., Béjaoui, M., Sherief, L. M., Christou, S., Cosmi, C., Pasqua, O. E. D., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30100-9 · Cited by 74
Management of the aging beta-thalassemia transfusion-dependent population – The Italian experience
Pinto, V. M., Poggi, M., Russo, R., Giusti, A., & Forni, G. L. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100594 · Cited by 71
Guerra, A., Oikonomidou, P. R., Sinha, S., Zhang, J., Presti, V. L., Hamilton, C. R., Breda, L., Casu, C., La, P., Martins, A. C., et al. (2019) · Blood · doi:10.1182/blood.2019001057 · Cited by 66
The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia
Lechauve, C., Keith, J., Khandros, E., Fowler, S., Mayberry, K. D., Freiwan, A., Thom, C. S., Delbini, P., Boada-Romero, E., Zhang, J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav4881 · Cited by 65
Self-citationAge-related changes in adaptation to severe anemia in childhood in developing countries
O’Donnell, A., Premawardhena, A., Arambepola, M., Allen, S. J., Peto, T., Fisher, C., Rees, D. C., Olivieri, N. F., & Weatherall, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703424104 · Cited by 59
Frangoul, H., Bobruff, Y., Cappellini, M. D., Corbacioglu, S., Fernandez, C. M., de la Fuente, J., Grupp, S. A., Handgretinger, R., Ho, T. W., Imren, S., et al. (2020) · Blood · doi:10.1182/blood-2020-139575 · Cited by 54
Self-citationCalvaruso, G., Vitrano, A., Maggio, R. D., Lai, E., Colletta, G., Quota, A., Gerardi, C., Rigoli, L. C., Sacco, M., Pitrolo, L., et al. (2015) · American Journal of Hematology · doi:10.1002/ajh.24024 · Cited by 48
A novel molecular basis for β thalassemia intermedia poses new questions about its pathophysiology
Premawardhena, A., Fisher, C. A., Olivieri, N. F., de Silva, S., Sloane‐Stanley, J., Wood, W. G., & Weatherall, D. J. (2005) · Blood · doi:10.1182/blood-2005-02-0593 · Cited by 47
Transfusion practices and complications in thalassemia
Lal, A., Wong, T. E., Andrews, J. C., Balasa, V., Chung, J. H., Forester, C. M., Ikeda, A. K., Keel, S., Pagano, M. B., Puthenveetil, G., et al. (2018) · Transfusion · doi:10.1111/trf.14875 · Cited by 39
Thalassemia Major: Transplantation or Transfusion and Chelation
Mohamed, S. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.05.022 · Cited by 38
Hemoglobin level and morbidity in non-transfusion-dependent thalassemia
Taher, A. T., Musallam, K. M., Saliba, A. N., Garziadei, G., & Cappellini, M. D. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.05.011 · Cited by 30
Self-citationPatel, K., Bhivandkar, S., Desai, R., & Antin, T. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3557-5 · Cited by 16
β-Thalassemia heterozygote state detrimentally affects health expectation
Graffeo, L., Vitrano, A., Scondotto, S., Dardanoni, G., Addario, W. P., Giambona, A., Sacco, M., Maggio, R. D., Renda, D., Taormina, F., et al. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.06.009 · Cited by 11
Cited by
Hepcidin and Iron in Health and Disease
Nemeth, E., & Ganz, T. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-032816 · Cited by 457
Kattamis, A., Kwiatkowski, J. L., & Aydinok, Y. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00536-0 · Cited by 313
Farmakis, D., Porter, J., Taher, A., Domenica Cappellini, M., Angastiniotis, M., Eleftheriou, A., & Taskforce, F. T. 2. T. G. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000732 · Cited by 307
Self-citationBetibeglogene Autotemcel Gene Therapy for Non–β 0 /β 0 Genotype β-Thalassemia
Locatelli, F., Thompson, A. A., Kwiatkowski, J. L., Porter, J. B., Thrasher, A. J., Hongeng, S., Sauer, M. G., Thuret, I., Lal, A., Algeri, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2113206 · Cited by 283
Tuo, Y., Li, Y., Li, Y., Ma, J., Yang, X., Wu, S., Jin, J., & He, Z. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102619 · Cited by 283
Metadata
- Authors
- Taher, A. T., Musallam, K. M., & Cappellini, M. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-02-25
- Volume
- 384
- Issue
- 8
- Pages
- 727-743
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4243712789
- Cited by
- 477
- References
- 66
- FWCI
- 28.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.